Fisher Asset Management
LIV

Fisher Asset Management’s SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) LIV Stock Holding History

Fisher Asset Management’s Portfolio LIV Stock Details LIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-32,917
Closed – – 725
2016
Q1 		$0 Hold
32,917
– – ﹤0.01% 747
2015
Q4 		$0 Hold
32,917
– – ﹤0.01% 770
2015
Q3 		$0 Hold
32,917
– – ﹤0.01% 707
2015
Q2 		$0 Hold
32,917
– – ﹤0.01% 615
2015
Q1 		$0 Hold
32,917
– – ﹤0.01% 604
2014
Q4 		$0 Hold
32,917
– – ﹤0.01% 606
2014
Q3 		$0 Hold
32,917
– – ﹤0.01% 587
2014
Q2 		$0 Hold
32,917
– – ﹤0.01% 593
2014
Q1 		$0 Hold
32,917
– – ﹤0.01% 556
2013
Q4 		$0 Hold
32,917
– – ﹤0.01% 546
2013
Q3 		$0 Hold
32,917
– – ﹤0.01% 531
2013
Q2 		$0 Buy
+32,917
New – ﹤0.01% 494

Fisher Asset Management's LIV Position: Q2 2016 in Review

Fisher Asset Management sold out of SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) (LIV) in Q2 2016, closing a stake of 32,917 shares.

Fisher Asset Management first reported a position in LIV in Q2 2013 and held it in 12 quarters. The position peaked at $0 in Q1 2016. 0 funds tracked by Wall St. Rank hold LIV as of Q2 2016.

  • Fisher Asset Management reported no remaining SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) position as of Q2 2016 after selling out during the quarter.
  • Fisher Asset Management sold 32,917 SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) shares in Q2 2016.
  • Fisher Asset Management first reported a position in SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) in Q2 2013 and held it in 12 quarters.
  • Fisher Asset Management's SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) position peaked at $0 in Q1 2016.
  • 0 funds tracked by Wall St. Rank held SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) as of Q2 2016.

Based on Fisher Asset Management's 13F filing for Q2 2016, filed 12 Jul 2016.